Publications by authors named "Honglei Ge"

Claim this Profile
D
Development and application of a UHPLC-MS/MS method for the simultaneous determination of firmonertinib and its main metabolite AST-5902 in rat plasma: a study on the drug interaction between firmonertinib and paxlovid.
Peng-Fei Tang, Su-Su Bao, Wei-Fei Xie, Zhong-Xiang Xiao, Xue-Meng Wu, Hong-Lei Ge

Front Pharmacol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
pH-sensitive supramolecular self-assembled peptide hydrogel for the treatment of esophageal cancer.
Gaobing Ye, Shiyao Luo, Hajra Zafar, Honglei Ge, Binbin Liu

Front Pharmacol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel UHPLC‒MS/MS method for quantitative analysis of zanubrutinib in rat plasma: application to an in vivo interaction study between zanubrutinib and triazole antifungal.
Peng-Fei Tang, Su-Su Bao, Zhong-Xiang Xiao, Wei-Fei Xie, Xue-Meng Wu, Hong-Lei Ge

BMC Chem· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional characterization of wild-type and 24 CYP2D6 allelic variants on gefitinib metabolism in vitro.
Ping Fang, Xiang Zheng, Jiayang He, Honglei Ge, Pengfei Tang

Drug Des Devel Ther· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of Liver Carcinoma Cell Invasion and Metastasis by Knockdown of Cullin7 In Vitro and In Vivo.
Donghui Zhang, Genling Yang, Xidong Li, Cheng Xu, Honglei Ge

Oncol Res· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis